As a co-founder of Bio Therapeutic Molecules Inc. (BTMI), Owen brings fifteen years of experience in the pharmaceutical sector with a wide range of industry expertise in brand and generic strategic definition, organizational design, product development, project management, analytical development, formulation development, product innovation and commercialization. In addition, his strong ties to the academic space, as Adjunct Associate Professor in the Waterloo School of Pharmacy, give him a unique mix of research understanding and industrial execution to effectively evaluate potential and drive the value growth of ideas, assets and business for clients and partners.
Owen started his career as a research scientist at Eli Lilly Canada where he had positions of increasing responsibility from Associate Senior Scientist through Group Leader and finally as Associate Director of the Canadian Analytical Research Laboratories where he led the development of small and large molecule therapeutics. Prior to establishing BTMI, Owen held multiple Director level roles at Accucaps Industries Ltd., where he grew and delivered a global product, capability and technology development portfolio through leadership of formulation, analytical, innovation and project management organizations.